Injectable study treatment for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study tests an investigational injectable medicine (IN-B00009) to see how well it controls blood sugar in adults with type 2 diabetes that is not well managed by diet and exercise alone. If you qualify, you may receive the study drug and will be monitored closely to see if it helps lower your blood sugar safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 75 years old
- Your body mass index (BMI) is between 20 and 35 — a measure of body size based on height and weight
- You have been diagnosed with type 2 diabetes for at least 12 weeks
- You have not taken any diabetes pills or other glucose-lowering medicines in the past 5 weeks (or longer)
- Your average blood sugar (HbA1c) is between 7.0% and 11.0% at the time of the study screening
- You agree to use contraception if you are able to become pregnant during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, LY4057996, in people with type 1 or type 2 diabetes and in healthy volunteers. It aims to see if the drug is safe and how it works in the body.
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
This study tests an investigational drug called HS-20094 to see how well it controls blood sugar in people with type 2 diabetes. It may help you manage your diabetes better if diet and exercise alone are not enough.
This trial tests a new injected drug (UBT251) for people with type 2 diabetes who haven't been able to control their blood sugar with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels safely.
This study tests an investigational injection called SYH2069 that may help lower blood sugar in people with type 2 diabetes who are already on metformin. It aims to see if the injection is safe and effective when added to diet, exercise, and metformin.
This early-stage study tests a new injectable medication (UBT38006) in healthy adult men to understand how safe it is and how the body processes it. Researchers want to make sure the injection doesn't cause serious side effects and works as expected.
Hear when a new Diabetes (DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.